One-stop Evaluation of Hypertrophic Cardiomyopathy in Cardiac Magnetic Resonance
Enrolling by invitation
Conditions studied: Hypertrophic Cardiomyopathy (HCM)
In brief
This is a multi-center, observational study aiming to establish a precision diagnosis scheme and multi-dimensional risk prediction models for Hypertrophic Cardiomyopathy (HCM). The study plans to enroll 10000 adult HCM patients. It will integrate genetic testing, advanced cardiac imaging (echocardiography and cardiac magnetic resonance), and biomarker analysis to develop early diagnosis, differential diagnosis, and new risk prediction models for sudden cardiac death (SCD) and heart failure in HCM patients. Participants will undergo baseline assessments and be followed up every six months for up to 3 years to track clinical outcomes. This study is non-interventional and does not involve any investigational drugs or devices.
Key facts
- Study ID
- NCT07336290
- Run by
- Minjie Lu
- People needed
- 10000
- Starts
- 2010-01-01
- Expected to finish
- 2030-12-30
- Last updated by the study team
- 2026-01-28
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A maximal left ventricular wall thickness of ≥ 12 mm in any segment at end-diastole, as measured by echocardiography or Cardiac Magnetic Resonance (CMR)
You may not qualify if…
- Presence of any contraindication to CMR examination.
- Unwillingness to participate in the study or to provide informed consent.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.